CARB-X awards Specific Diagnostics $1.7 million

Create PDF

CARB-X, which stands for Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, is a public-private partnership established in 2016 that provides financial and scientific support to accelerate drug-resistant bacterial infection research projects through the early stages of product development
CARB-X, 514-914-8974
Specific Diagnostics, 650-938-2030